{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:44:37Z","timestamp":1790858677398,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.arth.2023.05.071","type":"journal-article","created":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T09:40:06Z","timestamp":1685871606000},"page":"2311-2315.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Does Semaglutide Use Decrease Complications and Costs Following Total Knee Arthroplasty?"],"prefix":"10.1016","volume":"38","author":[{"given":"Matthew L.","family":"Magruder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1172-9166","authenticated-orcid":false,"given":"Vincent J.H.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel N.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Sasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orry","family":"Erez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2023.05.071_bib1","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.RVW.17.00146","article-title":"Diabetes and hyperglycemia in lower-extremity total joint arthroplasty: clinical epidemiology, outcomes, and management","volume":"6","author":"Rudy","year":"2018","journal-title":"JBJS Rev"},{"key":"10.1016\/j.arth.2023.05.071_bib2","series-title":"National diabetes statistics report 2022","year":"2022"},{"key":"10.1016\/j.arth.2023.05.071_bib3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.arth.2022.03.003","article-title":"Projected prevalence of obesity in primary total knee arthroplasty: how big will the problem get?","volume":"37","author":"Carender","year":"2022","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.05.071_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11999-014-3668-9","article-title":"The John Insall Award: morbid obesity independently impacts complications, mortality, and resource use after TKA","volume":"473","author":"D'Apuzzo","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2023.05.071_bib5","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.arth.2016.02.062","article-title":"Risk and cost of 90-day complications in morbidly and superobese patients after total knee arthroplasty","volume":"31","author":"Meller","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.05.071_bib6","first-page":"3752","article-title":"Prevalence and risk of infection in patients with diabetes following primary total knee arthroplasty: a global systematic review and meta-analysis of 120,754 knees","volume":"11","author":"Ahmad","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.arth.2023.05.071_bib7","first-page":"83","article-title":"The effects of obesity and morbid obesity on outcomes in TKA","volume":"26","author":"McElroy","year":"2013","journal-title":"J\u00a0Knee Surg"},{"key":"10.1016\/j.arth.2023.05.071_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2519\/jospt.2021.9515","article-title":"Diabetes mellitus blunts the symptoms, physical function, and health-related quality of life benefits of total knee arthroplasty: a systematic review with meta-analysis of data from more than 17 000 patients","volume":"51","author":"Na","year":"2021","journal-title":"J\u00a0Orthop Sports Phys Ther"},{"key":"10.1016\/j.arth.2023.05.071_bib9","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00167-016-4249-0","article-title":"Inadequate pre-operative glycaemic control in patients with diabetes mellitus adversely influences functional recovery after total knee arthroplasty: patients with impaired glycaemic control exhibit poorer functional outcomes at 1-year post-arthroplasty","volume":"25","author":"Brock","year":"2017","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.arth.2023.05.071_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejim.2010.02.006","article-title":"Preoperative hyperglycemia predicts infected total knee replacement","volume":"21","author":"J\u00e4msen","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.arth.2023.05.071_bib11","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2106\/JBJS.H.00116","article-title":"The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty","volume":"91","author":"Marchant","year":"2009","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2023.05.071_bib12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2106\/JBJS.18.01136","article-title":"Preoperative weight loss for morbidly obese patients undergoing total knee arthroplasty: determining the necessary amount","volume":"101","author":"Keeney","year":"2019","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2023.05.071_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.6722","article-title":"Effect of bariatric surgery on risk of complications after total knee arthroplasty: a randomized clinical trial","volume":"5","author":"Dowsey","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arth.2023.05.071_bib14","first-page":"61","article-title":"Clinical impact of semaglutide, a glucagon-like peptide-1 receptor agonist, on obesity management: a review","volume":"14","author":"Alorfi","year":"2022","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.arth.2023.05.071_bib15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2023.05.071_bib16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2023.05.071_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","volume":"5","author":"Sorli","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.arth.2023.05.071_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jim-2021-001952","article-title":"Wegovy (semaglutide): a new weight loss drug for chronic weight management","volume":"70","author":"Singh","year":"2022","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.arth.2023.05.071_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40265-018-0871-0","article-title":"Semaglutide: first global approval","volume":"78","author":"Dhillon","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.arth.2023.05.071_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13346-021-01000-w","article-title":"Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery","volume":"12","author":"Lewis","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.arth.2023.05.071_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2106\/JBJS.20.01535","article-title":"Metformin use is associated with fewer complications in patients with type-2 diabetes undergoing total knee arthroplasty: a propensity score-matched analysis","volume":"103","author":"Wilson","year":"2021","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2023.05.071_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.arth.2023.05.071_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2023.05.071_bib24","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2023.05.071_bib25","first-page":"288","article-title":"Gastrointestinal incretins-glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) beyond pleiotropic physiological effects are involved in pathophysiology of atherosclerosis and coronary artery disease-state of the art","volume":"11","author":"Jonik","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.arth.2023.05.071_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.peptides.2018.09.002","article-title":"Glucagon-like peptide-1 receptor action in the vasculature","volume":"111","author":"Almutairi","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.arth.2023.05.071_bib27","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.arth.2023.05.071_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/EJE-16-0507","article-title":"Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial","volume":"176","author":"Smits","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arth.2023.05.071_bib29","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1210\/en.2013-1934","article-title":"GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody","volume":"155","author":"Pyke","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.arth.2023.05.071_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.arth.2023.05.071_bib31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2023.05.071_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.mcna.2020.02.011","article-title":"Sepsis and septic shock - basics of diagnosis, pathophysiology and clinical decision making","volume":"104","author":"Font","year":"2020","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.arth.2023.05.071_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102511","article-title":"Semaglutide for the treatment of type 2 diabetes mellitus: a systematic review and network meta-analysis of safety and efficacy outcomes","volume":"16","author":"Zaazouee","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.arth.2023.05.071_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.arth.2021.10.006","article-title":"Incidence and predictors of prosthetic joint infection following primary total knee arthroplasty: a 15-year population-based cohort study","volume":"37","year":"2022","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.05.071_bib35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.arth.2021.09.021","article-title":"Obesity, comorbidities, and prior operations additively increase failure in 2-stage revision total knee arthroplasty for prosthetic joint infection","volume":"37","author":"Christiner","year":"2022","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.05.071_bib36","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.J.01935","article-title":"Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis","volume":"94","author":"J\u00e4msen","year":"2012","journal-title":"J\u00a0Bone Joint Surg Am"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540323006149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540323006149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:45:42Z","timestamp":1760121942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540323006149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0883540323006149"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2023.05.071","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Semaglutide Use Decrease Complications and Costs Following Total Knee Arthroplasty?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2023.05.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}